We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immucell (ICCC) - Potential Treatment for Cryptosporidium
An SI Board Since May 1996
Posts SubjectMarks Bans
46 2 0
Emcee:  Steve Type:  Unmoderated
The following was taken from the company's most recent 10K:

"ImmuCell Corporation (the "Company") is a biotechnology company that primarily develops, manufactures and markets milk-derived passive antibody products to prevent and/or treat gastrointestinal infections in both humans and animals. Using its core technology, the Company has developed proprietary methods for the production of commercial quantities of pathogen-specific antibodies from cows' milk. FIRST DEFENSE{R}, which has been approved by the United States Department of Agriculture ("USDA"), is the first product using this technology to be commercialized by the Company. Currently, this product is the only USDA-licensed, bivalent (effective on combatting two different infectious agents) scours preventive product in capsule form available on the market. The Company is investing in research and development that could lead to the commercialization of new products incorporating these proprietary methods for the prevention and/or treatment of gastrointestinal infections in humans.

From its inception in 1982, the Company has engaged in the research and development of both infectious disease diagnostic tests and products for therapeutic and preventive uses against certain infectious diseases in animals and humans. Since 1991, this product development effort has focused more principally on gastrointestinal diseases. Recently, the Company has diversified its product development pipeline in two significant ways. First, the Company has utilized the knowledge gained developing a passive antibody product to treat or prevent a gastrointestinal infection caused by CRYPTOSPORIDIUM PARVUM to develop a method to detect the presence of this dangerous parasite in public water supplies. The Company intends to begin beta testing in 1996 to evaluate the performance of the method under actual field conditions. Secondly, the Company has utilized both its expertise in processing proteins from cows' milk and its exclusive world-wide license to certain purification technology to develop a process to separate specialty proteins from cheese whey."
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
46ImmuCell Announces Increase in Product Sales and Continued Profitability [graphiDr_of_Microcaps-5/27/2013 <eom>Dr_of_Microcaps-1/12/2008 <eom>Dr_of_Microcaps-5/6/2007
43Private investor question and ICCC answer can be found at WS Transcript web siteaknahow-6/30/2000
42 1st quarter report: Any comments?
41 News on DiffGAM trials.
40 Somebody please call IR and confirm ASAP!! From the Yahoo rumor mill: Subj: AForYourEyesOnly-2/26/1998
39 Thanks Ed, I'll read up a little more before bothering you again. Please ForYourEyesOnly-2/11/1998
38 THC, Have you read posts 8&9 on this thread. That's the big potential hEd-2/11/1998
37 Thanks Ed! I like what's happening, but I still don't see the massive ForYourEyesOnly-2/11/1998
36 OK THC here's your info, just give me a cut of your profits. WPI is a commEd-2/11/1998
35 Thanks, but I live in Japan so its tough for me to call him. Would you be kindForYourEyesOnly-2/10/1998
34 THC, since I just spoke to Mike Brigham, the CFO, yesterday why don't you gEd-2/10/1998
33 The insider trading is clean, only buys, no sells. This looks great!! A few qForYourEyesOnly-2/10/1998
32 Today I spoke to ICCC CFO, Mike Brigham, he said that results of the field testEd-2/9/1998
31 I saw in Barons today that two insiders have recently been buying stock. PrettyEd-2/4/1998
30 Jonathan, what's your take on todays news release? I thought we'd be seEd-10/24/1997
29 How do you like their SBIR grant of 710 MM for studying traveller's diarheaJonathan Rothschild-10/4/1997
28 I like Enzon, but just sold it after it's news release. Have owned it and tJonathan Rothschild-8/11/1997
27 Off Topic. You might want to check out the Enzon thread. It's a biotech I Ed-8/6/1997
26 This company has executed on all of its projects this year. Although the DiffgaJonathan Rothschild-8/6/1997
25 News looks good, wish the stock would reflect the bright prospects. EdEd-7/31/1997
23 I spoke to CFO Mike Brigham today. STill very positive. Lactoferrin is in finalEd-7/12/1997
22 Check out today's press release from Immucell re: crypto diagnostic. This sJonathan Rothschild-6/11/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):